238 related articles for article (PubMed ID: 28414756)
21. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
22. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma.
Wistuba II; Montellano FD; Milchgrub S; Virmani AK; Behrens C; Chen H; Ahmadian M; Nowak JA; Muller C; Minna JD; Gazdar AF
Cancer Res; 1997 Aug; 57(15):3154-8. PubMed ID: 9242443
[TBL] [Abstract][Full Text] [Related]
23. Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer.
Butler D; Collins C; Mabruk M; Leader MB; Kay EW
Gynecol Oncol; 2002 Aug; 86(2):144-9. PubMed ID: 12144820
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Gong Y; Deavers M; Silva EG; Jan YJ; Cogdell DE; Luthra R; Lin E; Lai HC; Zhang W; Sneige N
J Clin Microbiol; 2008 Jan; 46(1):274-80. PubMed ID: 17977987
[TBL] [Abstract][Full Text] [Related]
25. Human telomerase gene and high-risk human papillomavirus infection are related to cervical intraepithelial neoplasia.
Zhao XY; Cui Y; Jiang SF; Liu KJ; Han HQ; Liu XS; Li Y
Asian Pac J Cancer Prev; 2015; 16(2):693-7. PubMed ID: 25684510
[TBL] [Abstract][Full Text] [Related]
26. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
27. [Expression of FHIT genes in CIN and cervical carcinoma and the relationship between FHIT gene and p53 and HPV16/18].
Zhang WM; Shuai CX; Zheng FY; Huang YP; Wang QJ; Zhu-Hua ; He QX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):452-5. PubMed ID: 17152494
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism.
Hu Z; Zhu D; Wang W; Li W; Jia W; Zeng X; Ding W; Yu L; Wang X; Wang L; Shen H; Zhang C; Liu H; Liu X; Zhao Y; Fang X; Li S; Chen W; Tang T; Fu A; Wang Z; Chen G; Gao Q; Li S; Xi L; Wang C; Liao S; Ma X; Wu P; Li K; Wang S; Zhou J; Wang J; Xu X; Wang H; Ma D
Nat Genet; 2015 Feb; 47(2):158-63. PubMed ID: 25581428
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
Futai M; Watanabe J; Jobo T; Tsunoda S; Nishimura Y; Watanabe K; Okayasu I; Unno N
Int J Gynecol Cancer; 2009 Nov; 19(8):1396-401. PubMed ID: 20009896
[TBL] [Abstract][Full Text] [Related]
30. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
31. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.
Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X
J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025
[TBL] [Abstract][Full Text] [Related]
32. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
[TBL] [Abstract][Full Text] [Related]
33. The correlation between FHIT, P53 and MMR genes in human papillomavirus-associated cervical carcinoma.
Bahnassy AA; Zekri AR; Madbouly MS; El-Naggar M; El-Khelany ZF; El-Merzebany MM
J Egypt Natl Canc Inst; 2006 Sep; 18(3):191-202. PubMed ID: 17671528
[TBL] [Abstract][Full Text] [Related]
34. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.
Lin ZH; Shen XH; Jin Z; Kim Y; Lee E; Kim H; Kim I
Pathol Int; 2005 Aug; 55(8):491-6. PubMed ID: 15998377
[TBL] [Abstract][Full Text] [Related]
36. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
[TBL] [Abstract][Full Text] [Related]
37. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ
Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043
[TBL] [Abstract][Full Text] [Related]
38. Correlation between laminin-5 immunohistochemistry and human papillomavirus status in squamous cervical carcinoma.
Boulet GA; Schrauwen I; Sahebali S; Horvath C; Depuydt CE; Vereecken A; Broeck DV; Van Marck EA; Bogers JJ
J Clin Pathol; 2007 Aug; 60(8):896-901. PubMed ID: 17660333
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
[TBL] [Abstract][Full Text] [Related]
40. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
